HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.

AbstractBACKGROUND & AIMS:
Rheumatoid arthritis (RA) is complicated by cytokine-driven alterations in protein and energy metabolism and consequent muscle wasting (cachexia). The aim of this randomised controlled trial was to investigate the efficacy of a mixture of beta-hydroxy-beta-methylbutyrate, glutamine and arginine (HMB/GLN/ARG) as nutritional treatment for rheumatoid cachexia.
METHODS:
Forty RA patients supplemented their diet with either HMB/GLN/ARG or a nitrogen (7.19 g/day) and calorie (180 kcal/day) balanced mixture of alanine, glutamic acid, glycine, and serine (placebo) for 12 weeks. Body composition and other outcomes were assessed at baseline and follow-up, and analysed by mixed ANOVA.
RESULTS:
Dietary supplementation with HMB/GLN/ARG was not superior to placebo in the treatment of rheumatoid cachexia (groupxtime interactions P>0.05 for all outcomes). Both amino acid mixtures significantly increased (main effect of time) fat-free mass (727+/-1186 g, P<0.01), total body protein (719+/-1703 g, P=0.02), arms (112+/-183 g, P<0.01) and legs (283+/-534 g, P<0.01) lean mass, and some measures of physical function. No significant adverse event occurred during the study, but patients in the HMB/GLN/ARG group reported fewer gastrointestinal complaints compared to placebo.
CONCLUSIONS:
Dietary supplementation with HMB/GLN/ARG is better tolerated but not more effective in reversing cachexia in RA patients compared to the mixture of other non-essential amino acids used as placebo. Further controlled studies are necessary to confirm the beneficial anabolic and functional effects of increased nitrogen intake in this population.
AuthorsSamuele Marcora, Andrew Lemmey, Peter Maddison
JournalClinical nutrition (Edinburgh, Scotland) (Clin Nutr) Vol. 24 Issue 3 Pg. 442-54 (Jun 2005) ISSN: 0261-5614 [Print] England
PMID15896432 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Valerates
  • Glutamine
  • beta-hydroxyisovaleric acid
  • Arginine
Topics
  • Arginine (administration & dosage)
  • Arthritis, Rheumatoid (complications, metabolism, psychology)
  • Body Composition (physiology)
  • Body Mass Index
  • Cachexia (diet therapy, etiology, psychology)
  • Dietary Supplements
  • Double-Blind Method
  • Female
  • Glutamine (administration & dosage)
  • Hand Strength (physiology)
  • Humans
  • Male
  • Middle Aged
  • Surveys and Questionnaires
  • Valerates (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: